WSJ US BusinessSanofi Ends a Covid-19 Vaccine Effort

September 28, 20210
https://www.gmi-co.com/wp-content/uploads/2021/09/sanofi-ends-a-covid-19-vaccine-effort.jpg

Sanofi SA won’t proceed with the development of one of its experimental Covid-19 vaccines, saying it didn’t make sense to go forward in an already-crowded market.

The decision comes despite promising early results for the shot. The French healthcare giant said Tuesday that the vaccine—a so-called mRNA shot that uses the same technology as shots developed by Pfizer Inc. and Moderna Inc. —produced neutralizing antibodies against the virus in early-stage clinical trials. But it said it had decided not to proceed with larger studies, called Phase 3 trials, which would be required to win regulatory approval.

Leave a Reply

Your email address will not be published. Required fields are marked *

700 Louisiana Street , Houston TX. 77002
(+1) 832-390-2738
info@gmi-co.com

Follow us:

FREE CONSULTATION

Calls may be recorded for quality and training purposes.

Copyright © GMI 2020